Composition
- Active ingredients
- LASMIDITAN 100MG
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- LASMIDITAN 100MG · TabletANDA219350-001 · Tentative approval
- LASMIDITAN 50MG · TabletANDA219350-002 · Tentative approval
- LASMIDITAN 100MG · TabletThis page
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application ANDA219669.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Lasmiditan
- Dosage form
- Tablet
- Applicant
- Humanwell Pharmaceutical US Inc
- Status
- Tentative approval
- FDA approval
- 19 Dec 2025
- Application
- ANDA219669-002